These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 29981923)

  • 41. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deep Learning for Drug-Induced Liver Injury.
    Xu Y; Dai Z; Chen F; Gao S; Pei J; Lai L
    J Chem Inf Model; 2015 Oct; 55(10):2085-93. PubMed ID: 26437739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human liver organoid screening platform for DILI risk prediction.
    Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
    J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury.
    McEuen K; Borlak J; Tong W; Chen M
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissecting the molecular pathophysiology of drug-induced liver injury.
    Ye H; Nelson LJ; Gómez Del Moral M; Martínez-Naves E; Cubero FJ
    World J Gastroenterol; 2018 Apr; 24(13):1373-1385. PubMed ID: 29632419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports.
    Zhu XW; Li SJ
    Toxicol Sci; 2017 Aug; 158(2):391-400. PubMed ID: 28521054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The trends in predicting drug-induced liver injury].
    Takemura A; Ito K
    Nihon Yakurigaku Zasshi; 2020; 155(6):401-405. PubMed ID: 33132258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.
    Shin HK; Kang MG; Park D; Park T; Yoon S
    Front Pharmacol; 2020; 11():67. PubMed ID: 32116729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of binary classification models for assessment of drug-induced liver injury in humans using a large set of FDA-approved drugs.
    Zhang H; Zhang HR; Hu ML; Qi HZ
    J Pharmacol Toxicol Methods; 2022; 116():107185. PubMed ID: 35623583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of clinically relevant drug-induced liver injury from structure using machine learning.
    Hammann F; Schöning V; Drewe J
    J Appl Toxicol; 2019 Mar; 39(3):412-419. PubMed ID: 30325042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials.
    Avigan MI; Bjornsson ES; Pasanen M; Cooper C; Andrade RJ; Watkins PB; Lewis JH; Merz M
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S19-31. PubMed ID: 25352325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Drug-induced liver injury].
    Björnsson ES
    Laeknabladid; 2010 Mar; 96(3):175-82. PubMed ID: 20197596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a Battery of
    Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
    Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.
    Kuijper IA; Yang H; Van De Water B; Beltman JB
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):5-17. PubMed ID: 27609146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced liver injury: what was new in 2008?
    Liss G; Lewis JH
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):843-60. PubMed ID: 19505188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive Model for Drug-Induced Liver Injury Using Deep Neural Networks Based on Substructure Space.
    Kang MG; Kang NS
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.